A glimpse about Grifols Egypt in 2024

GEPD key moments and significant milestones achieved during 2024

At Grifols Egypt for Plasma Derivatives (GEPD) we are dedicated to enhancing the health and well-being of all Egyptians by providing access to safe and high-quality lifesaving medicines derived from human plasma.

Plasma derived medicines are unique biological therapies used to treat rare, chronic and, in some cases, life-threatening diseases.

We are building a national world-class integrated plasma infrastructure that will strengthen the country’s healthcare system. 

Latest news